Predicting neutropenia risk in patients with cancer using electronic data.
Clinical guidelines recommending the use of myeloid growth factors are largely based on the prescribed chemotherapy regimen. The guidelines suggest that oncologists consider patient-specific characteristics when prescribing granulocyte-colony stimulating factor (G-CSF) prophylaxis; however, a mechanism to quantify individual patient risk is lacking. Readily available electronic health record (EHR) data can provide patient-specific information needed for individualized neutropenia risk estimation. An evidence-based, individualized neutropenia risk estimation algorithm has been developed. This [...]
Author(s): Pawloski, Pamala A, Thomas, Avis J, Kane, Sheryl, Vazquez-Benitez, Gabriela, Shapiro, Gary R, Lyman, Gary H
DOI: 10.1093/jamia/ocw131